Synthesis and evaluation of new fluorinated anti-tubercular compounds

Iranian Journal of Pharmaceutical Research

Volumn 13, Issue 1, 2014, Pages 115-126

  Esfahanizadeh, Marjan ^a,b   Omidi, Koroush ^b   Kauffman, Joel ^c   Gudarzi, Ali ^a   Zahedani, Shahram Shahraki ^d   Amidi, Salimeh ^a   Kobarfard, Farzad ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF THE SCIENCES   (United States)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti tuberculosis drugs; Fluorinated analogs; PAS; Pyrazinamide; Thiacetazone

Indexed keywords

3 AMINOPYRAZINE 2 CARBOXYLATE; 3 FLUOROPYRAZINE 2 CARBOXAMIDE; 3 FLUOROPYRAZINE 2 CARBOXYLIC ACID; 4 ACETAMIDO 3 BROMOBENZALDEHYDE THIOSEMICARBAZONE; 4 ACETAMIDO 3 CHLOROBENZALDEHYDE; 4 ACETAMIDO 3 CHLOROBENZALDEHYDE THIOSEMICARBAZONE; 4 ACETAMIDO 3 FLUOROBENZALDEHYDE; 4 ACETAMIDO 3 FLUOROBENZALDEHYDE THIOSEMICARBAZONE; 4 ACETAMIDO 3 IODOBENZALDEHYDE; 4 ACETAMIDO 3 IODOBENZALDEHYDE THIOSEMICARBAZONE; 4 ACETAMIDO 3 IODOBENZONITRILE; 4 AMINO 5 FLUOROSALICYLIC ACID; 4 AMINOSALICYLIC ACID METHYL ESTER; AMINOSALICYLIC ACID; METHYL 3 FLUOROPYRAZINE 2 CARBOXYLATE; METHYL 4 ACETAMIDO 5 FLUOROSALICYLATE; METHYL 4 ACETAMIDOSALICYLATE; PYRAZINAMIDE; RIFAMPICIN; THIOACETAZONE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; GROWTH INHIBITION; IC 50; INFRARED RADIATION; MELTING POINT; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MTT ASSAY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; THIN LAYER CHROMATOGRAPHY;

EID: 84903627023     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. The World Health Organization (WHO) Global Tuberculosis Report 2012. Available from: URL: www.who.int/entity/tb/publications/en.
2. Mahjub R, Samad A, Kumar Y, Shahryar M, Khosa RL, Jain J and Bansal S. 3D QSAR Studies of 1,3,4-oxadiazole derivatives as anti-mycobacterial agents. Iran. J. Pharm. Res. (2009) 8: 163-167.
3. Gillespie SH and Kennedy N. Fluoroquinolones: a new treatment for tuberculosis. Int. J. Tuberc. Lung Dis. (1998) 2: 265-271.
4. Filler R. Organofluorine compounds in medicinal chemistry and biomedical applications. In: Filler R. (ed.). Studies in Organic Chemistry. Vol 48. Elsevier, New York (1993) 1-23.
5. Thayer JD and Seligman RB. Anti-biotics Chemotherapy (1955) 5: 129.
6. Behnisch R, Mietzsch F and Schmidt H. Chemical studies on thiosemicarbazones with particular reference to anti-tuberculous activity. Am. Rev. Tuberc. (1950) 61: 1-7.
7. Van Es T and Staskun B. Aldehydes from aromatic nitrils; 4-formylbenzenesulfonamide. Org. Syn. (1988) 6: 631.
8. Suzuki H. Direct iodination of polyalkylbenzenes. Org. Syn. (1988) 6: 700.
9. Newman M. N-methylpyrrolidone as solvent for reaction of aryl halides with cuprous cyanide. J. Org. Chem. (1961) 26: 2525.
10. Vikramjeet J, Balasubramanian N and Munish A. A review of biological potential of pyrazinamid derivatives. Hygia. J. D. Med. (2012) 4: 1-6.
11. Collins L and Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Ant-imicrob. Agent Chemother. (1997) 41: 1004-1009.
12. 4 in action: tamed fluorine at your service. J. Fluorine Chem. (1998) 87: 1-17.
13. Alahari A, Trivelli X, Guerardel Y, Dover LG, Besra GS, Sacchettini JC, Reynolds RC, Coxon GD and Kremer L. Thiacetazone, an anti-tubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PLoS One. (2007) 2: 1343.
14. Haj Mohammad Ebrahim Tehrani K, Kobarfard F, Azerang P, Mehravar M, Soleimani Z, Ghazaleh Ghavami G and Sardari S., Synthesis and Antimycobacterial Activity of Symmetric Thiocarbohydrazone Derivatives against Mycobacterium bovis BCG. Iran. J. Pharm. Res. (2013) 12: 331-346.
15. Almasirad H, A Samiee-Sadr S and Shafiee A. Synthesis and antimycobacterial activity of 2-(phenylthio) benzoylarylhydrazone derivatives. Iran. J. Pharm. Res. (2011) 10: 727-731.